435 related articles for article (PubMed ID: 17499227)
1. Angiotensin II-mediated oxidative stress and inflammation mediate the age-dependent cardiomyopathy in ACE2 null mice.
Oudit GY; Kassiri Z; Patel MP; Chappell M; Butany J; Backx PH; Tsushima RG; Scholey JW; Khokha R; Penninger JM
Cardiovasc Res; 2007 Jul; 75(1):29-39. PubMed ID: 17499227
[TBL] [Abstract][Full Text] [Related]
2. Cardioprotective effects mediated by angiotensin II type 1 receptor blockade and enhancing angiotensin 1-7 in experimental heart failure in angiotensin-converting enzyme 2-null mice.
Patel VB; Bodiga S; Fan D; Das SK; Wang Z; Wang W; Basu R; Zhong J; Kassiri Z; Oudit GY
Hypertension; 2012 Jun; 59(6):1195-203. PubMed ID: 22508831
[TBL] [Abstract][Full Text] [Related]
3. Loss of angiotensin-converting enzyme 2 accelerates maladaptive left ventricular remodeling in response to myocardial infarction.
Kassiri Z; Zhong J; Guo D; Basu R; Wang X; Liu PP; Scholey JW; Penninger JM; Oudit GY
Circ Heart Fail; 2009 Sep; 2(5):446-55. PubMed ID: 19808375
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin II induced proteolytic cleavage of myocardial ACE2 is mediated by TACE/ADAM-17: a positive feedback mechanism in the RAS.
Patel VB; Clarke N; Wang Z; Fan D; Parajuli N; Basu R; Putko B; Kassiri Z; Turner AJ; Oudit GY
J Mol Cell Cardiol; 2014 Jan; 66():167-76. PubMed ID: 24332999
[TBL] [Abstract][Full Text] [Related]
5. Prevention of angiotensin II-mediated renal oxidative stress, inflammation, and fibrosis by angiotensin-converting enzyme 2.
Zhong J; Guo D; Chen CB; Wang W; Schuster M; Loibner H; Penninger JM; Scholey JW; Kassiri Z; Oudit GY
Hypertension; 2011 Feb; 57(2):314-22. PubMed ID: 21189404
[TBL] [Abstract][Full Text] [Related]
6. Enhanced susceptibility to biomechanical stress in ACE2 null mice is prevented by loss of the p47(phox) NADPH oxidase subunit.
Bodiga S; Zhong JC; Wang W; Basu R; Lo J; Liu GC; Guo D; Holland SM; Scholey JW; Penninger JM; Kassiri Z; Oudit GY
Cardiovasc Res; 2011 Jul; 91(1):151-61. PubMed ID: 21285291
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin-converting enzyme 2 is a critical determinant of angiotensin II-induced loss of vascular smooth muscle cells and adverse vascular remodeling.
Patel VB; Zhong JC; Fan D; Basu R; Morton JS; Parajuli N; McMurtry MS; Davidge ST; Kassiri Z; Oudit GY
Hypertension; 2014 Jul; 64(1):157-64. PubMed ID: 24799609
[TBL] [Abstract][Full Text] [Related]
8. Deletion of angiotensin-converting enzyme 2 exacerbates renal inflammation and injury in apolipoprotein E-deficient mice through modulation of the nephrin and TNF-alpha-TNFRSF1A signaling.
Jin HY; Chen LJ; Zhang ZZ; Xu YL; Song B; Xu R; Oudit GY; Gao PJ; Zhu DL; Zhong JC
J Transl Med; 2015 Aug; 13():255. PubMed ID: 26245758
[TBL] [Abstract][Full Text] [Related]
9. Candesartan ameliorates cardiac dysfunction observed in angiotensin-converting enzyme 2-deficient mice.
Nakamura K; Koibuchi N; Nishimatsu H; Higashikuni Y; Hirata Y; Kugiyama K; Nagai R; Sata M
Hypertens Res; 2008 Oct; 31(10):1953-61. PubMed ID: 19015603
[TBL] [Abstract][Full Text] [Related]
10. Cardiac protective effects of irbesartan via the PPAR-gamma signaling pathway in angiotensin-converting enzyme 2-deficient mice.
Zhang ZZ; Shang QH; Jin HY; Song B; Oudit GY; Lu L; Zhou T; Xu YL; Gao PJ; Zhu DL; Penninger JM; Zhong JC
J Transl Med; 2013 Sep; 11():229. PubMed ID: 24067190
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin-converting enzyme 2 suppresses pathological hypertrophy, myocardial fibrosis, and cardiac dysfunction.
Zhong J; Basu R; Guo D; Chow FL; Byrns S; Schuster M; Loibner H; Wang XH; Penninger JM; Kassiri Z; Oudit GY
Circulation; 2010 Aug; 122(7):717-28, 18 p following 728. PubMed ID: 20679547
[TBL] [Abstract][Full Text] [Related]
12. Loss of angiotensin-converting enzyme-2 exacerbates diabetic cardiovascular complications and leads to systolic and vascular dysfunction: a critical role of the angiotensin II/AT1 receptor axis.
Patel VB; Bodiga S; Basu R; Das SK; Wang W; Wang Z; Lo J; Grant MB; Zhong J; Kassiri Z; Oudit GY
Circ Res; 2012 May; 110(10):1322-35. PubMed ID: 22474255
[TBL] [Abstract][Full Text] [Related]
13. The counterregulating role of ACE2 and ACE2-mediated angiotensin 1-7 signaling against angiotensin II stimulation in vascular cells.
Hayashi N; Yamamoto K; Ohishi M; Tatara Y; Takeya Y; Shiota A; Oguro R; Iwamoto Y; Takeda M; Rakugi H
Hypertens Res; 2010 Nov; 33(11):1182-5. PubMed ID: 20703229
[TBL] [Abstract][Full Text] [Related]
14. Possible role of angiotensin-converting enzyme 2 and activation of angiotensin II type 2 receptor by angiotensin-(1-7) in improvement of vascular remodeling by angiotensin II type 1 receptor blockade.
Ohshima K; Mogi M; Nakaoka H; Iwanami J; Min LJ; Kanno H; Tsukuda K; Chisaka T; Bai HY; Wang XL; Ogimoto A; Higaki J; Horiuchi M
Hypertension; 2014 Mar; 63(3):e53-9. PubMed ID: 24379178
[TBL] [Abstract][Full Text] [Related]
15. Expression of renin-angiotensin system and peroxisome proliferator-activated receptors in alcoholic cardiomyopathy.
Jing L; Li WM; Zhou LJ; Li S; Kou JJ; Song J
Alcohol Clin Exp Res; 2008 Nov; 32(11):1999-2007. PubMed ID: 18783396
[TBL] [Abstract][Full Text] [Related]
16. ACE2 deficiency enhances angiotensin II-mediated aortic profilin-1 expression, inflammation and peroxynitrite production.
Jin HY; Song B; Oudit GY; Davidge ST; Yu HM; Jiang YY; Gao PJ; Zhu DL; Ning G; Kassiri Z; Penninger JM; Zhong JC
PLoS One; 2012; 7(6):e38502. PubMed ID: 22693641
[TBL] [Abstract][Full Text] [Related]
17. Deletion of angiotensin-converting enzyme 2 accelerates pressure overload-induced cardiac dysfunction by increasing local angiotensin II.
Yamamoto K; Ohishi M; Katsuya T; Ito N; Ikushima M; Kaibe M; Tatara Y; Shiota A; Sugano S; Takeda S; Rakugi H; Ogihara T
Hypertension; 2006 Apr; 47(4):718-26. PubMed ID: 16505206
[TBL] [Abstract][Full Text] [Related]
18. Role of angiotensin-converting enzyme (ACE and ACE2) imbalance on tourniquet-induced remote kidney injury in a mouse hindlimb ischemia-reperfusion model.
Yang XH; Wang YH; Wang JJ; Liu YC; Deng W; Qin C; Gao JL; Zhang LY
Peptides; 2012 Jul; 36(1):60-70. PubMed ID: 22580272
[TBL] [Abstract][Full Text] [Related]
19. Counter-regulatory effects played by the ACE - Ang II - AT1 and ACE2 - Ang-(1-7) - Mas axes on the reactive oxygen species-mediated control of vascular function: perspectives to pharmacological approaches in controlling vascular complications.
Pernomian L; Pernomian L; Baraldi Araújo Restini C
Vasa; 2014 Nov; 43(6):404-14. PubMed ID: 25339158
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin-(1-7) inhibits angiotensin II-stimulated phosphorylation of MAP kinases in proximal tubular cells.
Su Z; Zimpelmann J; Burns KD
Kidney Int; 2006 Jun; 69(12):2212-8. PubMed ID: 16672906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]